Cargando…
Murine xenograft bioreactors for human immunopeptidome discovery
The study of peptides presented by MHC class I and class II molecules is limited by the need for relatively large cell numbers, especially when studying post-translationally modified or otherwise rare peptide species. To overcome this problem, we pose the hypothesis that human cells grown as xenogra...
Autores principales: | Heather, James M., Myers, Paisley T., Shi, Feng, Aziz-Zanjani, Mohammad Ovais, Mahoney, Keira E., Perez, Matthew, Morin, Benjamin, Brittsan, Christine, Shabanowitz, Jeffrey, Hunt, Donald F., Cobbold, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898210/ https://www.ncbi.nlm.nih.gov/pubmed/31811195 http://dx.doi.org/10.1038/s41598-019-54700-2 |
Ejemplares similares
-
MHC Phosphopeptides: Promising Targets for Immunotherapy of Cancer and Other Chronic Diseases
por: Mahoney, Keira E., et al.
Publicado: (2021) -
Cloud Computing Based Immunopeptidomics Utilizing Community Curated Variant Libraries Simplifies and Improves Neo-Antigen Discovery in Metastatic Melanoma
por: Prakash, Amol, et al.
Publicado: (2021) -
Tumor Infiltrating Lymphocytes Target HLA-I Phosphopeptides Derived From Cancer Signaling in Colorectal Cancer
por: Penny, Sarah A., et al.
Publicado: (2021) -
MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma
por: Engelhard, Victor H, et al.
Publicado: (2020) -
A tissue-based draft map of the murine MHC class I immunopeptidome
por: Schuster, Heiko, et al.
Publicado: (2018)